Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 38 5 IN PLASTIC CONTAINER versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 38 5 IN PLASTIC CONTAINER versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 38.5% IN PLASTIC CONTAINER vs DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a simple sugar that provides caloric support and serves as a source of energy. It increases blood glucose levels, which is essential for cellular metabolism, particularly in the brain and erythrocytes.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Intravenous administration. Dose depends on clinical condition; typically 50-100 mL of 38.5% dextrose (19.25-38.5 g glucose) for hypoglycemia. Maximum infusion rate: 0.5 g/kg/h.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
None Documented
None Documented
~30 minutes (endogenous glucose turnover; clinical context: continuous infusion required for maintenance as glucose is rapidly metabolized)
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
100% renal (excreted as carbon dioxide and water after metabolism; negligible unchanged glucose in urine under normoglycemia; renal threshold ~180 mg/dL)
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Category C
Category C
IV Fluid
IV Fluid